Rose Perri

Chief Executive Officer
Rose C. Perri, President has held management and overseen operations for both private and public companies for the past 20+ years. She has served in a number of start-up biotech companies where her roles included those of principal shareholder, Senior Executive and Board Member. She, along with her late brother, E. Mark Perri, founded Biomin Therapeutics Corporation, a start-up biotech company, in 1990. Biomin was a publically-traded company both on the Toronto and Vancouver Stock Exchanges. Rose managed the day-to-day corporate affairs for this R&D biotech company whose research focused in the area of bone cancer treatments.In 1995, Rose was a co-founder of Generex Biotechnology Corporation, a start-up drug delivery company whose main research and development product was a buccal delivery of insulin. The company initially went public in February, 1998 and moved up Bulletin Board to SmallCaps to the NASDAQ Stock Exchange where it traded for over a decade. Her roles in the 16 years at Generex Biotechnology Corporation evolved from a co-Founder to holding her executive positions, namely Chief Operating Officer and Chief Financial Officer. Her positions have allowed her the opportunity to expand her network within the pharmaceutical, biotechnology, regulatory and financial industries. She will utilize her resources in this area to attract and manage various potential partnerships and alliances.She has also served as a manager of a family-owned property investment/property management and investment company with responsibilities of overseeing the portfolio. This business has been operational since the 1980’s and continues to exist and operation to this present day.

Anna Gluskin

Chairman Emeritus

Anna Gluskin (Chief Executive Officer) has over 30 years’ experience in discovering and developing opportunities in the area of biotechnology pharmaceutical and consumer health products. While she is currently managing her own investments in a number of consumer health products and drug delivery she has served as the Chief Executive Officer and President of Generex Biotechnology Corporation, a company that has developed a proprietary alternative (non-invasive; non-injectable) drug delivery system. Ms. Gluskin was a Founder of Generex Biotechnology Corporation and in her role as CEO she was instrumental in raising over $400 million for the company. Since its inception in 1995 Generex has developed an oral (buccal delivery insulin spray, Oral-lyn) and a platform from which a number of applications have been tested and others identified. An over-the-counter spray product pipeline was also developed and was marketed around the globe.

Prior to her Executive Management position at Generex Biotechnology, Ms. Gluskin served as a Director of Interlock Consolidated Corporation, a Canadian public company, which was engaged in the sale and fabrication of pharmaceutical manufacturing facilities. Ms. Gluskin successfully participated in the set-up of pharmaceutical facilities in Russia and other countries in Eastern Europe.

Ms. Gluskin has a number of patents for innovative pharmaceutical drugs in her name. She holds a Masters Degree in Microbiology and Genetics from Moscow State University and an equivalent degree from the University of Toronto.


William D. Abajian

Vice Chairman, President and Chief Operating Officer

Mr. William (Bill) D. Abajian brings over 30 years experience in the pharmaceutical and biotechnology industry.   He started his career  at Electro Nucleonics Inc. in Fairfield, New Jersey where he served as the Vice President of Sales and Marketing between 1981-1988. While at Electro Nucleonics he developed, manufactured and sold blood chemistry and diagnostic kits.   Bill founded CPG Inc. in 1988 and served as its Chief Executive Officer until 2002.  In 2004, he founded The Abajian Group LLC.   He served as a Special Consultant of Advanced Biophotonics Inc. (formerly Omnicorder Technologies Inc.) commencing December 2004 and continued part-time until September, 2005. Soon after, Bill served as the Vice President, Global Business Development at Generex Biotechnology Corporation and held that position until July, 2011.   He also held the position of Chief Executive Officer, President and Treasurer and Director of Protect Pharmaceutical Corp. for a short period during 2010.

Bill serves as a trustee of Eva’s Village, a non-for-profit organization in Paterson, New Jersey and of St. Joseph’s Hospital in Paterson, New Jersey.